PMH21 PHARMACY COST IMPACT OF GUIDELINE-RECOMMENDED DOSING OF SECOND GERNERATION ANTIPSYCHOTICS IN SCHIZOPHRENIA
| Autor: | Chen, CC, Kim, E, Yu, Y, Kan, HJ, Whitehead, R |
|---|---|
| Zdroj: | In Value in Health 2008 11(3):A115-A115 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect